Scinai Immunotherapeutics regains compliance with Nasdaq listing rule Source: Seekingalpha
Author: Helitra.com
Veeva spikes on above-consensus earnings guidance Source: Seekingalpha
BrainsWay appoints Richard Bermudes, M.D. as CMO Source: Seekingalpha
Immunocore CFO to leave company Source: Seekingalpha
dentalcorp Holdings to make normal course issuer bid Source: Seekingalpha
Bayer bets $547M on therapies for RNA-driven cancers Source: Seekingalpha
Gain slips after early-stage data for Parkinson’s therapy Source: Seekingalpha
American Diversified to cancel 142M shares Source: Seekingalpha
BioCardia shares climb as it gets FDA clearance for its Morph DNA product family Source: Seekingalpha
Nuvectis gains on FDA’s orphan drug designation for cancer therapy Source: Seekingalpha
